Concentrix (CNXC) Q4 2025 earnings review
Top-Line Acceleration Overshadowed by $1.5B Impairment
Concentrix delivered its strongest revenue growth of the fiscal year in Q4 (+4.3% reported, +3.1% constant currency), beating the top end of its guidance. However, the report is dominated by a massive $1.52 billion non-cash goodwill impairment charge, driven by the company's depressed stock valuation, which swung GAAP results to a $1.48 billion loss. Operationally, profitability deteriorated: Non-GAAP operating margin compressed 150 basis points YoY to 12.7%, and Non-GAAP EPS fell 9.5%. While the FY26 outlook promises continued growth, the divergence between rising sales and shrinking margins remains a key friction point.
🐂 Bull Case
Top-line growth has accelerated for three consecutive quarters, moving from +1.3% (CC) in Q1 to +3.1% in Q4. FY26 guidance calls for continued expansion (+1.5% to +3.0% CC), suggesting the demand environment is stabilizing.
The Banking, Financial Services, and Insurance segment surged 12% YoY, a significant acceleration that offset weakness in Tech. This vertical mix shift suggests Concentrix is winning in complex, high-value regulatory environments.
🐻 Bear Case
Non-GAAP operating margins fell 150bps YoY in Q4. More concerning is the FY26 guidance: the midpoint implies an operating margin of ~12.5%, down from FY25's 12.8% and FY24's 13.7%. Operating leverage is moving in the wrong direction.
Management booked a $1.52B impairment charge, admitting the market capitalization does not support the carrying value of past acquisitions (likely Webhelp). While non-cash, it is a severe admission of value destruction.
⚖️ Verdict: 🔴
Bearish. While revenue acceleration is a positive signal, the substantial margin degradation and the $1.5B impairment charge indicate structural issues. The company is growing sales but becoming less profitable per dollar earned, and FY26 guidance does not forecast a return to margin expansion.
Key Themes
$1.52 Billion Goodwill Impairment
Concentrix recorded a $1.52 billion non-cash goodwill impairment charge in Q4. Management explicitly cited the 'trading range for the Company’s stock price and market capitalization' as the primary trigger. This wiped out full-year GAAP earnings, resulting in a $1.28 billion net loss for FY25. This signals that the premiums paid for past acquisitions (Webhelp) are not being recognized by the public market.
Margin Compression Trend
Profitability metrics are deteriorating. Non-GAAP operating margin dropped from 14.2% in 24Q4 to 12.7% in 25Q4. Adjusted EBITDA margin similarly compressed from 16.5% to 14.8%. The company faces negative operating leverage, likely due to competitive pricing pressures, mix shift, or elevated investment costs that are not yet yielding efficiency gains.
Financial Services (BFSI) Powering Growth
The BFSI vertical is the standout performer, accelerating to 12% YoY growth in Q4 (up from flat/low growth earlier in the year). Comms & Media also posted strong +8% growth. These segments are successfully offsetting declines in the tech sector.
Tech & Healthcare Lagging
Two key high-value verticals remain in contraction. Technology and Consumer Electronics revenue fell 2% YoY, and Healthcare declined 1%. Since these are typically higher-margin segments than Retail or Media, their underperformance likely contributes to the overall margin compression.
Solid Cash Flow Conversion
Despite the GAAP loss, cash generation remains a bright spot. FY25 Adjusted Free Cash Flow reached $626 million, landing within the guidance range ($625-650M). FY26 guidance projects further growth to $630-650M, ensuring the dividend and buyback programs remain funded.
Other KPIs
Decelerating. Decreased 9.5% YoY from $3.26 in 24Q4. Despite revenue growing 4.3%, earnings power declined significantly due to margin compression and higher tax/interest implications relative to operating income.
Accelerating. Up 4.3% reported and 3.1% constant currency. This beat the company's previous guidance range ($2,525-2,550M) and marks the highest quarterly growth rate of FY25.
Stable. The company returned $258M to shareholders via dividends ($90M estimated) and buybacks ($168M estimated), while reducing net debt by $184M. Buyback authorization has $438.6M remaining.
Guidance
Decelerating. Implies 1.5% to 2.5% constant currency growth, slightly lower than the 3.1% CC growth achieved in 25Q4. Includes a ~290bps positive FX impact.
Decelerating. The midpoint ($2.63) represents a ~10% decline YoY vs 25Q1 ($2.79) and a 4% decline vs 24Q1 ($2.75). Profitability continues to face headwinds.
Stable. Implies 1.5% to 3.0% constant currency growth, generally consistent with the exit rate of FY25. Shows continued modest organic expansion.
Accelerating. Midpoint ($11.78) implies ~5% growth over FY25 ($11.22), though this is primarily driven by revenue scale rather than margin expansion, as implied operating margins remain flat/down.
Key Questions
Impairment Trigger Details
The $1.52B impairment is massive. Beyond the stock price, has there been a fundamental change in the long-term cash flow assumptions for the legacy Webhelp business or other reporting units?
Margin Compression Root Cause
Non-GAAP operating margins compressed 150bps YoY in Q4. Is this primarily pricing pressure in the Tech vertical, or are there one-time integration/AI investment costs that will roll off in FY26?
Technology Vertical Turnaround
The Technology segment remains negative (-2%). When do you expect this vertical to stabilize, and are AI-agent headwinds impacting volumes in this specific cohort?
FY26 Margin Bridge
Guidance implies FY26 operating margins of ~12.5%, which is below FY25's 12.8%. Why is operating leverage negative despite projected revenue growth of up to 3%?